Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[HIV-tuberculosis coinfection].

Sibylle Bévilacqua1, Christian Rabaud, Thierry May

  • 1Service des Maladies Infectieuses et Tropicales, Hôpitaux de Brabois, CHU de Nancy, Allée du Morvan, 54511 Vandoeuvre-lès-Nancy Cedex. sibylle.bevilacqua@free.fr

Annales De Medecine Interne
|May 31, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-stage revision for chronic fistulized infected total knee arthroplasty achieves infection-free survival comparable to non-fistulized cases.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2026
Same author

Brain <sup>18</sup>F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristics.

European journal of nuclear medicine and molecular imaging·2022
Same author

Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Journal of Crohn's & colitis·2022
Same author

Incidence and characteristics of COVID-19 in French professional football players during the 2020-2021 season.

Infectious diseases now·2022
Same author

SARS-CoV-2 seroprevalence in healthcare workers and risk factors.

Infection, disease & health·2022
Same author

Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France.

The lancet. Healthy longevity·2021

Coinfection with human immunodeficiency virus (HIV) and tuberculosis presents significant global health challenges. Effective management involves tailored treatment and careful consideration of drug interactions for improved patient outcomes.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Immunology

Context:

  • Coinfection with HIV and tuberculosis is a critical global health issue, particularly in Sub-Saharan Africa and Southeast Asia.
  • Approximately one-third of tuberculosis patients are coinfected with HIV, exacerbating disease progression and mortality.
  • The interplay between HIV and tuberculosis complicates diagnosis and treatment, necessitating specialized management strategies.

Purpose:

  • To outline the challenges and recommended management strategies for patients coinfected with HIV and tuberculosis.
  • To highlight the importance of early diagnosis and appropriate treatment protocols for coinfection.
  • To address drug interactions and "paradoxical" reactions associated with combined antiretroviral and anti-tuberculosis therapies.

Summary:

Related Experiment Videos

  • Coinfected patients require conventional 9-month anti-tuberculosis treatment with multiple drugs, often achieving favorable outcomes.
  • Drug interactions between antiretroviral and anti-tuberculosis medications pose a significant challenge, limiting treatment options.
  • A recommended approach involves treating tuberculosis first, followed by the introduction of antiretroviral therapy after six weeks.
  • Preventive therapy for at-risk individuals includes a 2-month regimen of rifampicin and pyrazinamide.

Impact:

  • Improved management of HIV-tuberculosis coinfection can lead to better patient prognoses and reduced mortality.
  • Understanding drug interactions is crucial for optimizing combined treatment regimens and enhancing patient adherence.
  • Effective preventive strategies can reduce the incidence of tuberculosis in HIV-positive individuals.